Gossamer Bio
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $11,489 | $9,889 | $9,379 | $9,480 |
Gross Profit | 11,489 | 9,889 | 9,379 | 9,480 |
EBITDA | -35,316 | -33,550 | -31,626 | -28,103 |
EBIT | -35,529 | -33,892 | -32,701 | -29,201 |
Net Income | -38,273 | -36,638 | -33,029 | -30,803 |
Net Change In Cash | 11,489 | 9,889 | 9,379 | 9,480 |
Free Cash Flow | -47,114 | -39,750 | -35,481 | -32,033 |
Cash | 26,309 | 29,021 | 46,074 | 28,464 |
Basic Shares | 227,275 | 226,818 | 226,604 | 226,346 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $114,701 | $0 | $0 | $0 |
Gross Profit | 114,701 | -4,385 | -4,429 | -5,167 |
EBITDA | -39,967 | -172,152 | -211,069 | -209,322 |
EBIT | -44,118 | -173,759 | -215,498 | -214,489 |
Net Income | -56,528 | -179,817 | -240,228 | -249,076 |
Net Change In Cash | 114,701 | 0 | 0 | 0 |
Cost of Revenue | -70,977 | -302,988 | ||
Free Cash Flow | -3,468 | -159,158 | -187,507 | -190,511 |
Cash | 46,074 | 32,109 | 111,973 | 183,403 |
Basic Shares | 226,228 | 225,572 | 84,574 | 74,843 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.17 |
2025-03-31 | -$0.16 |
2024-12-31 | -$0.15 |
